View up-to-date information on Denali Therapeutics Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| AU2021224200A1 | Application | Engineered anti-HER2 bispecific proteins | A61K2039/505; A61K39/001106; A61K45/06; C07K16/32; C07K2317/31; C07K2317/526; C07K2317/622; C07K2317/73; C07K2317/90; C07K2317/92 | September 08, 2022 |
| UA126231C2 | Grant | PYRIMIDIN-2-YLAMINO-1H-PYRAZOLS AS LRRK2 INHIBITORS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISORDERS | A61K31/506; A61K31/519; A61K31/5365; A61K31/5377; A61P1/04; A61P19/02; A61P21/00; A61P25/00; A61P25/14; A61P25/16; A61P25/28; A61P29/00; A61P35/00; A61P35/02; A61P43/00; C07B2200/05; C07B59/002; C07D401/14; C07D403/12; C07D403/14; C07D405/14; C07D409/14; C07D413/14; C07D417/14; C07D487/04; C07D491/20; C07D498/04 | September 07, 2022 |
| EP3866861A4 | Search Report | VERFAHREN ZUR BEHANDLUNG UND ÜBERWACHUNG VON MIT PROGRANULIN ASSOZIIERTEN ERKRANKUNGEN | G01N2405/04; G01N2500/00; G01N2560/00; G01N2800/2814; G01N2800/50; G01N2800/52; G01N33/6893; G01N33/92 | September 07, 2022 |
| IL294655A | Application | Anti-trem2 antibodies and methods of use thereof | A61K2039/505; A61K2039/545; C07K16/2803; C07K2317/24; C07K2317/33; C07K2317/526; C07K2317/53; C07K2317/55; C07K2317/565; C07K2317/71; C07K2317/74; C07K2317/75; C07K2317/90; C07K2317/92; C07K2317/94; C07K2319/30 | September 01, 2022 |
| ECSP22054464A | Application | ANTICUERPOS ANTI-TREM2 Y M?TODOS PARA UTILIZARLOS | A61K2039/505; C07K16/2803; C07K2317/24; C07K2317/33; C07K2317/526; C07K2317/53; C07K2317/55; C07K2317/71; C07K2317/75; C07K2317/90; C07K2317/92 | August 31, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer